NeuroSense Therapeutics News

NeuroSense Therapeutics | 424B5: Prospectus

Apr 12 16:35 ET

NeuroSense Therapeutics | EFFECT: Others

Apr 9 06:04 ET

NeuroSense Therapeutics | EFFECT: Others

Apr 9 06:04 ET

NeuroSense Therapeutics | 424B3: Prospectus

Dec 27, 2023 00:00 ET

NeuroSense Therapeutics | 424B3: Prospectus

Dec 14, 2023 16:30 ET

NeuroSense Therapeutics | 424B3: Prospectus

Dec 5, 2023 15:15 ET

NeuroSense Therapeutics | 424B3: Prospectus

Dec 5, 2023 15:00 ET

NeuroSense Therapeutics | EFFECT: Others

Dec 5, 2023 00:15 ET

NeuroSense Therapeutics | 424B3: Prospectus

Sep 7, 2023 16:31 ET

NeuroSense Therapeutics | EFFECT: Others

Sep 6, 2023 00:15 ET

NeuroSense Therapeutics | 424B5: Prospectus

Jun 23, 2023 16:05 ET

NeuroSense Therapeutics | 424B5: Prospectus

Jun 22, 2023 06:12 ET

NeuroSense Therapeutics | 424B5: Prospectus

Apr 14, 2023 16:31 ET

NeuroSense Therapeutics | EFFECT: Others

Jan 31, 2023 00:15 ET

NeuroSense Therapeutics | 424B3: Prospectus

Jul 28, 2022 08:00 ET

NeuroSense Therapeutics | 424B3: Prospectus

Apr 15, 2022 07:36 ET

NeuroSense Therapeutics | 424B4: Prospectus

Dec 10, 2021 06:12 ET

NeuroSense Therapeutics | EFFECT: Others

Dec 9, 2021 00:15 ET

NeuroSense Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Dec 6, 2021 10:29 ET

NeuroSense Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

Nov 18, 2021 10:33 ET